Sleep Initiation and Maintenance Disorders Clinical Trial
Official title:
"Get up" - The Sleep Study in Oppegard (Stå Opp - Søvnstudien i Oppegård)
A randomized, controlled study to examine the effect of group treatment for insomnia (CBT-I) in an outpatient clinic compared with waiting list and treatment-as-usual (sleep-hygiene based educational course)
Insomnia is a large public health concern with latest reports pointing to almost 15 % of the
population in Norway having insomnia (Pallesen, Sivertsen, Nordhus, & Bjorvatn, 2014). At the
same time there is a scientific consensus about how to best treat insomnia (CBT-I), and it is
empirically proven that this is quite effective treatment (Okajima, Komada & Inoue, 2011).
We therefore want to conduct a study to examine if CBT-I treatment in an public outpatient
clinic is effective compared with waiting list and a psychoeducational course.
The design is a randomized controlled study with three different conditions (CBT-I versus
waiting list versus TAU) that will be compared over time. We will use an A-B-design which can
effectively compare the different conditions in the study. We have recruited a total of 62
patients, and completed a individual session with each of these individuals resulting in a
total admission of 38 participants in the study. The remaining 24 patients either didn't fit
the selection criteria, or we were unable to get in touch with them to agree on an
appointment.
Of the 38 participants enrolled in the study, 16 will get CBT-I, Group based treatment during
May and June of 2017 (a total of seven sessions over nine weeks), and the remaining 22 will
get the same treatment in September and October 2017. The maximum number of patients per
group is eight (8) and we randomized whether participants got assigned to treatment in
May/June or September/October.
We measure all participants at the individual pre-screening (T1), Treatment Group 1 and 2
gets treatment in May and June and will be measured in every other treatment session (2,4,6
and 7) From now on called (T2, T3, T4, T5). Treatment Group 3,4 and 5 (all getting treatment
i September/October) is measured at T2 and T5. T1 was conducted during the last week of April
and T5 is towards the end of June 2017.
Treatment Group 3, 4 and 5 will start their treatment and be measured at session 2 (T6) in
mid-September, and Treatment Group 1 and 2 will also be measured at this point. Treatment
Group 3, 4 and 5 will then be measured at treatment session 4,6 and 7, just like treatment
Group 1 and 2 was during their treatment. (From now on T7, T8, T9). Treatment Groups 1 and 2
will also be measured at T9.
The treatment-as-usual condition is conducted in Nesodden kommune, and it is a
psychoeducative, learning based course. This course consists of 4 sessions, and the
participants is measured at session 1,3 and 4 in addition to a 6 months follow-up measure.
They also get measured at pre-screening. We expect about 16 participants to complete this
course.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
| Recruiting |
NCT05000528 -
Evaluation of the Effectiveness of Patient Therapeutic Education on Chronic Insomnia
|
N/A | |
| Completed |
NCT04661306 -
The Better Sleep for Supporters With Insomnia Study
|
N/A | |
| Completed |
NCT03673397 -
The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression
|
N/A | |
| Completed |
NCT01784614 -
A Study of LY2624803 in Japanese Participants With Transient Insomnia
|
Phase 1 | |
| Completed |
NCT00365261 -
Effect of Eszopiclone on Sleep Disturbance and Pain in Cancer
|
Phase 4 | |
| Completed |
NCT00380003 -
Efficacy Study of EVT 201 to Treat Insomnia
|
Phase 2 | |
| Completed |
NCT00183378 -
Using Behavioral Programs to Treat Sleep Problems in Individuals With Alzheimer's Disease
|
N/A | |
| Completed |
NCT00097604 -
Effects of Valerian on Sleep in Healthy Older Adults
|
Phase 2 | |
| Completed |
NCT00946530 -
Light Treatment for Sleep/Wake Disturbances in Alzheimer's Disease
|
N/A | |
| Completed |
NCT00630175 -
Evaluation of the Hypnotic Properties of Zolpidem-MR 12.5 mg and Zolpidem 10 mg Marketed Product Compared to Placebo in Patients With Primary Insomnia
|
Phase 3 | |
| Completed |
NCT00044629 -
Combined Behavioral/Pharmacological Therapy for Insomnia
|
Phase 2 | |
| Completed |
NCT00079664 -
Comparing Tai Chi Training to a Low-Stress Physical Activity to Enhance Sleep in Older Adults
|
Phase 1 | |
| Completed |
NCT01154023 -
Behavioral Intervention for Insomnia in Older Adults
|
N/A | |
| Recruiting |
NCT04417153 -
Who Benefits More? Optimising Mindfulness Based Interventions for Improved Psychological Outcomes
|
||
| Completed |
NCT04560595 -
Remote Guided Caffeine Reduction
|
N/A | |
| Recruiting |
NCT04986007 -
Addressing Nocturnal Sleep/Wake Effects on Risk of Suicide in Older Adults
|
N/A | |
| Completed |
NCT03852966 -
Better Sleep in Psychiatric Care - ADHD Pilot Study
|
N/A | |
| Terminated |
NCT00750919 -
Twenty-six Week Extension Trial of Org 50081 (Esmirtazapine) in Outpatients With Chronic Primary Insomnia (176003/P05721/MK-8265-007)
|
Phase 3 | |
| Recruiting |
NCT04550507 -
Mind-Body Interventions to Mitigate Effects of Media Use on Sleep in Early Adolescents
|
N/A |